Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ovarian cancer AND:

The relation between endometriosis and ovarian cancer - a review. Heidemann LN et al. Acta Obstet Gynecol Scand. (2014)

Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation. Weiderpass E et al. Mol Diagn Ther. (2015)

Ovarian cancer: diagnostic, biological and prognostic aspects. Davidson B et al. Womens Health (Lond). (2014)

Search results

Items: 1 to 20 of 106713

  • The following term was ignored: AND
  • See the search details.
1.

Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.

Samykutty A, Grizzle WE, Fouts BL, McNally MW, Chuong P, Thomas A, Chiba A, Otali D, Woloszynska A, Said N, Frederick PJ, Jasinski J, Liu J, McNally LR.

Biomaterials. 2018 Aug 4;182:114-126. doi: 10.1016/j.biomaterials.2018.08.001. [Epub ahead of print]

PMID:
30118979
2.

BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.

Cao P, Zhao S, Sun Z, Jiang N, Shang Y, Wang Y, Gu J, Li S.

Exp Cell Res. 2018 Aug 14. pii: S0014-4827(18)30675-X. doi: 10.1016/j.yexcr.2018.08.013. [Epub ahead of print]

PMID:
30118697
3.

A Feasibility Study of Restorative Yoga Versus Vigorous Yoga Intervention for Sedentary Breast and Ovarian Cancer Survivors.

Lapen K, Benusis L, Pearson S, Search B, Coleton M, Li QS, Sjoberg D, Konner J, Mao JJ, Deng G.

Int J Yoga Therap. 2018 Aug 17. doi: 10.17761/2018-00039. [Epub ahead of print]

PMID:
30117760
4.

A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models.

Parrish J, Lim KS, Baer K, Hooper GJ, Woodfield TBF.

Lab Chip. 2018 Aug 17. doi: 10.1039/c8lc00485d. [Epub ahead of print]

PMID:
30117514
5.

Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire.

Tsubamoto H, Ueda T, Inoue K, Isono-Nakata R, Saeki S, Kato Y, Shibahara H.

J Obstet Gynaecol Res. 2018 Aug 16. doi: 10.1111/jog.13784. [Epub ahead of print]

PMID:
30117238
6.

Recurrent pregnancy loss and future risk of female malignancies.

Charach R, Sheiner E, Beharier O, Sergienko R, Kessous R.

Arch Gynecol Obstet. 2018 Aug 16. doi: 10.1007/s00404-018-4868-4. [Epub ahead of print]

PMID:
30116931
7.

Role of plasma levels of CA-125 in predicting outcome of primary PCI after acute myocardial infarction in male patients.

Separham A, Abbasnezhad M, Shahnazarli G, Khoshbahar A.

J Cardiovasc Thorac Res. 2018;10(2):109-112. doi: 10.15171/jcvtr.2018.17. Epub 2018 May 21.

PMID:
30116510
8.

Effect of lanthanum chloride on tumor growth and apoptosis in human ovarian cancer cells and xenograft animal models.

Wang F, Zhu Y, Fang S, Li S, Liu S.

Exp Ther Med. 2018 Aug;16(2):1143-1148. doi: 10.3892/etm.2018.6299. Epub 2018 Jun 13.

PMID:
30116365
9.

Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer.

Sun Y, Yao Z, Zhao Z, Xiao H, Xia M, Zhu X, Jiang X, Sun C.

Exp Ther Med. 2018 Aug;16(2):1071-1078. doi: 10.3892/etm.2018.6342. Epub 2018 Jun 22.

PMID:
30116358
10.

Advances in the use of PARP inhibitor therapy for breast cancer.

McCann KE, Hurvitz SA.

Drugs Context. 2018 Aug 8;7:212540. doi: 10.7573/dic.212540. eCollection 2018. Review.

PMID:
30116283
11.

KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.

Han J, Wang F, Lan Y, Wang J, Nie C, Liang Y, Song R, Zheng T, Pan S, Pei T, Xie C, Yang G, Liu X, Zhu M, Wang Y, Liu Y, Meng F, Cui Y, Zhang B, Liu Y, Meng X, Zhang J, Liu L.

Oncogene. 2018 Aug 16. doi: 10.1038/s41388-018-0440-8. [Epub ahead of print]

PMID:
30115976
12.

CD44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer.

Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.

Cancer Res. 2018 Aug 16. pii: canres.3871.2017. doi: 10.1158/0008-5472.CAN-17-3871. [Epub ahead of print]

PMID:
30115698
13.

Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries.

You W, Symonds I, Henneberg M.

J Ovarian Res. 2018 Aug 16;11(1):68. doi: 10.1186/s13048-018-0441-9.

PMID:
30115095
14.

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.

Loessner D, Goettig P, Preis S, Felber J, Bronger H, Clements JA, Dorn J, Magdolen V.

Expert Opin Ther Targets. 2018 Aug 17. doi: 10.1080/14728222.2018.1512587. [Epub ahead of print]

PMID:
30114962
15.

Honokiol: An anticancer lignan.

Rauf A, Patel S, Imran M, AneelaMaalik, Arshad MU, Saeed F, Mabkhot YN, Al-Showiman SS, Ahmad N, Elsharkawy E.

Biomed Pharmacother. 2018 Aug 13;107:555-562. doi: 10.1016/j.biopha.2018.08.054. [Epub ahead of print] Review.

PMID:
30114639
16.

Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS-based non-targeted and targeted analyses.

Lu X, Li Y, Xia B, Bai Y, Zhang K, Zhang X, Xie H, Sun F, Hou Y, Li K.

Int J Cancer. 2018 Aug 16. doi: 10.1002/ijc.31807. [Epub ahead of print]

PMID:
30114318
17.

AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.

Sonigo C, Beau I, Grynberg M, Binart N.

FASEB J. 2018 Aug 16:fj201801089R. doi: 10.1096/fj.201801089R. [Epub ahead of print]

PMID:
30113879
18.

Vascular endothelial FSH-Receptor, a target of interest for cancer therapy.

Ghinea N.

Endocrinology. 2018 Aug 2. doi: 10.1210/en.2018-00466. [Epub ahead of print]

PMID:
30113652
19.

Comparison of gynecologic cancer risk factors, incidence and mortality trends between South Korea and Israel, 1999-2013.

Michaan N, Park SY, Won YJ, Lim MC.

Jpn J Clin Oncol. 2018 Aug 3. doi: 10.1093/jjco/hyy111. [Epub ahead of print]

PMID:
30113642
20.

Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.

Wang Y, Yang J, Yu M, Cao D, Zhang Y, Zong X, Shen K.

Medicine (Baltimore). 2018 Aug;97(33):e11838. doi: 10.1097/MD.0000000000011838.

Supplemental Content

Loading ...
Support Center